Hyundai Pharm Capital Reinvestment Ratio
Hyundai Pharm capital reinvestment ratio. Hyundai Pharm (004310) has a Capital Reinvestment Ratio of 0.46x as of May 2026, meaning it reinvests 0% of its operating cash flow (₩2.39 Billion) in capital expenditures (₩1.09 Billion). Check Hyundai Pharm (004310) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hyundai Pharm (2010–2022)
Capital reinvestment ratio of Hyundai Pharm from 2010 to 2022. This chart tracks Hyundai Pharm's Capital Reinvestment Ratio across 8 annual periods. Also explore how fast is Hyundai Pharm growing its equity to track the company's year-over-year net asset growth rate.
Hyundai Pharm Capital Reinvestment Ratio by Year (2010–2022)
Hyundai Pharm capital reinvestment ratio by year from 2010 to 2022. For the full cash flow conversion analysis, see Hyundai Pharm (004310) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.57x | ₩11.62 Billion | ₩6.58 Billion | ▼ -57.3% |
| 2021 | 1.33x | ₩5.13 Billion | ₩6.81 Billion | ▲ +123.9% |
| 2020 | 0.59x | ₩10.80 Billion | ₩6.40 Billion | ▲ +74.8% |
| 2019 | 0.34x | ₩6.96 Billion | ₩2.36 Billion | ▼ -64.0% |
| 2018 | 0.94x | ₩2.83 Billion | ₩2.67 Billion | ▲ +233.7% |
| 2013 | 0.28x | ₩7.95 Billion | ₩2.24 Billion | ▼ -52.0% |
| 2011 | 0.59x | ₩6.27 Billion | ₩3.68 Billion | ▼ -60.1% |
| 2010 | 1.47x | ₩2.68 Billion | ₩3.95 Billion | — |